Want to join the conversation?
$XLNX reported higher earnings in 1Q17, helped by higher operating income compared to 1Q16. Net income was $163MM or $0.61 per diluted share compared to $147.7MM or $0.55 per diluted share last year. Sales were $575MM in 1Q17, up 1% sequentially, and up 5% from 1Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?